Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 1, 1998, Pages 49-57

  Takahashi, Hirosi ^a   Kikuchi, Toru ^a   Shoji, Satoru ^a   Fujimura, Shigeru ^a   Lutfor, Afzalunnessa Binte ^a   Tokue, Yutaka ^a   Nukiwa, Toshihiro ^a   Watanabe, Akira ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BALOFLOXACIN; CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); LEVOFLOXACIN; OFLOXACIN; PAZUFLOXACIN; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TEMAFLOXACIN; TOSUFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG SENSITIVITY; GENE MUTATION; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; DIOXOLANES; DNA TOPOISOMERASE IV; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; GENES, BACTERIAL; HUMANS; PIPERAZINES; POINT MUTATION; POLYMERASE CHAIN REACTION; QUINOLONES; STAPHYLOCOCCUS AUREUS;

EID: 0031884029     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.1.49     Document Type: Article

References (35)

1. Shalit, I., Berger, S. A., Gorea, A. & Frimerman, H. (1989). Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital. Antimicrobial Agents and Chemotherapy 33, 593-4.
2. Schaefler, S. (1989). Methicillin-resistant Staphylococcus aureus resistant to quinolones. Journal of Clinical Microbiology 27, 335-6.
3. Takahashi, H., Shouji, S., Kikuchi, H., Watanabe, A., Honda, Y., Tokue, Y. et al. (1995). Changes in susceptibility of clinical isolates of Staphylococcus aureus to quinolones and other antibacterial agents from 1986 to 1993. Japanese Journal of Chemotherapy 43, 457-9.
4. Sreedharan, S., Oram, M., Jansen, B., Peterson, L. R. & Fisher, L. M. (1990). DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. Journal of Bacteriology 172, 7260-2.
5. Ito, H., Yoshida, H., Bogaki-Shonai, M., Niga, T., Hattori, H. & Nakamura, S. (1994). Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 38, 2014-23.
6. Gellert, M., Mizuuchi, K., O'Dea, M. H. & Nash, H. A. (1976). DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proceedings of the National Academy of Science of the USA 73, 3872-6.
7. Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A. et al. (1994). Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Molecular Microbiology 13, 641-53.
8. Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K. & Konno, M. (1990). Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. Journal of Bacteriology 172, 6942-9.
9. Sreedharan, S., Peterson, L. R. & Fisher, L. M. (1991). Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutation at serine-84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy 35, 2151-4.
10. Goswitz, J. J., Willard, K. E., Fasching, C. E. & Peterson, L. R. (1992). Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrobial Agents and Chemotherapy 36, 1166-9.
11. Fasching, C. E., Tenover, F. C., Slama, T. G., Fisher, L. M., Sreedharan, S., Oram, M. et al. (1991). gyrA mutations in coprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. Journal of Infectious Disease 164, 976-9.
12. Tokue, Y., Sugano, K., Saito, D., Noda, T., Ohkura, H., Shimosato, Y. et al. (1994). Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing. Antimicrobial Agents and Chemotherapy 38, 428-31.
13. Takahashi, H., Shouji, S., Kikuchi, H., Watanabe, A., Honda, Y., Tokue, Y. et al. (1995). Rate of occurrence of mutations at Ser-84 in Staphylococcus aureus DNA gyrase A protein. Japanese Journal of Chemotherapy 43, 515-9.
14. Hori, S., Oshita, Y., Utsui, Y. & Hiramatu, K. (1993). Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 37, 2278-84.
15. Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M. & Nakamura, S. (1991). Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrobial Agents and Chemotherapy 35, 1647-50.
16. Stein, D. C., Danaher, R. J. & Cook, T. M. (1991). Characterization of gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy 35, 622-6.
17. Kocagoz, T., Hackbarth, C. J., Unsal, I., Rosenberg, E. Y., Nikaido, H. & Chambers, H. F. (1996). Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrobial Agents and Chemotherapy 40, 1768-74.
18. Pan, X. S., Ambler, J., Mehter, S. & Fisher, L. M. (1996). Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40, 2321-6.
19. Yoshida, H., Bogaki, M., Nakamura, M. & Nakamura, S. (1990). Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrobial Agents and Chemotherapy 34, 1271-2.
20. Korten, V., Huang, W. M. & Murray, B. E. (1994). Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 38, 2091-4.
21. Kureushi, A., Diver, J. M., Beckthold, B., Schollaardt, T & Bryan, L. E. (1994). Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates. Antimicrobial Agents and Chemotherapy 38, 1944-52.
22. Rahman, M., Mauff, G., Levy, J., Couturier, M., Pulverer, G., Glasdorff, N. et al. (1994). Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrobial Agents and Chemotherapy 38, 2488-91.
23. Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B. et al. (1994). Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrobial Agents and Chemotherapy 38, 773-80.
24. Cambau, E., Sougakoff, W., Besson, M., Truffot-Pernot, C., Grosset, J. & Jarlier, V. (1994). Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. Journal of Infectious Disease 170, 479-83.
25. Wang, Y., Huang, W. M. & Taylor, D. E. (1993). Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistant mutations. Antimicrobial Agents and Chemotherapy 37, 457-63.
26. Vila, J., Ruiz, J., Goni, P., Marcos, A. & Jimenez de Anta, T. (1995). Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 39, 1201-3.
27. Kato. J., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S. & Suzuki, H. (1990). New topoisomerase essential for chromosome segregation in E. coli. Cell 63, 393-404.
28. Belland, R. J., Morrison, S. G., Ison, C. & Huang, W. M. (1994). Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Molecular Microbiology 14, 371-80.
29. Munoz, R. & de la Campa, A. G. (1996). ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrobial Agents and Chemotherapy 40, 2252-7.
30. Ferrero, L., Cameron, B. & Crouzet, J. (1995). Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 39, 1554-8.
31. Ng, E. Y., Trucksis, M. & Hooper, D. C. (1996). Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 40, 1881-8.
32. Breines, D. M., Ouabdesselam, S., Ng., E. Y., Tankovic, J., Shah, S., Soussy, C. J. et al. (1997). Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrobial Agents and Chemotherapy 41, 175-9.
33. Perichon, B., Tankovic, J. & Courvalin, P. (1997). Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 1166-7.
34. Nakamura, S., Nakamura, M., Kojima, T. & Yosida, H. (1989). gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrobial Agents and Chemotherapy 33, 254-5.
35. Perterson, L. R., Willard, K. E., Sinn, L. M., Fasching, C. E. & Gerding, D. N. (1993). GyrA sequence analysis of Staphylococcus aureus and methicillin-resistant S. aureus strains selected, in vitro, for high-level ciprofloxacin resistance. Diagnostic Microbiology and Infectious Disease 17, 97-101.